Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-185344
Filing Date
2025-08-21
Accepted
2025-08-21 16:30:21
Documents
70
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 6-K ocs-20250630.htm   iXBRL 6-K 113258
2 EX-99.1 ocs-ex99_1.htm   iXBRL EX-99.1 1963662
3 EX-99.2 ocs-ex99_2.htm EX-99.2 751159
4 EX-99.3 ocs-ex99_3.htm EX-99.3 212539
5 GRAPHIC img187686630_0.jpg GRAPHIC 11150
6 GRAPHIC img189533672_0.jpg GRAPHIC 28026
  Complete submission text file 0001193125-25-185344.txt   10694735

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ocs-20250630.xsd EX-101.SCH 2185259
73 EXTRACTED XBRL INSTANCE DOCUMENT ocs-20250630_htm.xml XML 1748466
Mailing Address BAHNHOFSTRASSE 7 ZUG V8 6300
Business Address BAHNHOFSTRASSE 7 ZUG V8 6300 617-937-2423
Oculis Holding AG (Filer) CIK: 0001953530 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41636 | Film No.: 251241228
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)